AN1
Click for more information
0.00% 0.8¢ anagenics limited

Ann: Cellmid's Evolis Patent to be Granted in China, page-9

  1. bread89
    412 Posts.
    lightbulb Created with Sketch. 26
    clock Created with Sketch.
    05/02/20
    23:30
    Post #: 42769620
    What's wrong with the announcement? With or without the virus, they have to report their latest progress, no? Does this piece of news brought any negative impact to the company amid the outbreak? Like ppl fear the virus so much that anything related with China will be beaten down... What's your logic behind? Totally senseless, no?
    CDY Price at posting: 20.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.690M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $336 42K

Buyers (Bids)

No. Vol. Price($)
3 1457234 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 14.19pm 12/07/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.